Weighing the value of completion nodal dissection for melanoma

Jason B. Liu; Karl Y Bilimoria

doi:10.1002/jso.24273

Weighing the value of completion nodal dissection for melanoma

Jason B. Liu^*, Karl Y Bilimoria

^*Corresponding author for this work

Surgery, Surgical Oncology Division

Research output: Contribution to journal › Review article

6 Scopus citations

Abstract

In the United States, approximately half of patients with a positive sentinel lymph node biopsy undergo a completion lymphadenectomy. Because of the equivocal survival benefits in pursuing a completion lymphadenectomy in these patients, surgeons must weigh the postoperative morbidity of the operation with concerns facing a patient's quality of life and risk of tumor recurrence. We discuss the value of a completion lymphadenectomy in light of the uncertainties facing this management strategy for melanoma. J. Surg. Oncol. 2016;114:281–287.

Original language	English (US)
Pages (from-to)	281-287
Number of pages	7
Journal	Journal of Surgical Oncology
Volume	114
Issue number	3
DOIs	https://doi.org/10.1002/jso.24273
State	Published - Sep 1 2016

Fingerprint

Keywords

lymphadenectomy
melanoma
sentinel lymph node
value

ASJC Scopus subject areas

Surgery
Oncology

Cite this

Liu, J. B., & Bilimoria, K. Y. (2016). Weighing the value of completion nodal dissection for melanoma. Journal of Surgical Oncology, 114(3), 281-287. https://doi.org/10.1002/jso.24273

@article{06cee831197b43e4acaaca84568aa3c2,

title = "Weighing the value of completion nodal dissection for melanoma",

abstract = "In the United States, approximately half of patients with a positive sentinel lymph node biopsy undergo a completion lymphadenectomy. Because of the equivocal survival benefits in pursuing a completion lymphadenectomy in these patients, surgeons must weigh the postoperative morbidity of the operation with concerns facing a patient's quality of life and risk of tumor recurrence. We discuss the value of a completion lymphadenectomy in light of the uncertainties facing this management strategy for melanoma. J. Surg. Oncol. 2016;114:281–287.",

keywords = "lymphadenectomy, melanoma, sentinel lymph node, value",

author = "Liu, {Jason B.} and Bilimoria, {Karl Y}",

year = "2016",

month = sep

day = "1",

doi = "10.1002/jso.24273",

language = "English (US)",

volume = "114",

pages = "281--287",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley-Liss Inc.",

number = "3",

}

TY - JOUR

T1 - Weighing the value of completion nodal dissection for melanoma

AU - Liu, Jason B.

AU - Bilimoria, Karl Y

PY - 2016/9/1

Y1 - 2016/9/1

N2 - In the United States, approximately half of patients with a positive sentinel lymph node biopsy undergo a completion lymphadenectomy. Because of the equivocal survival benefits in pursuing a completion lymphadenectomy in these patients, surgeons must weigh the postoperative morbidity of the operation with concerns facing a patient's quality of life and risk of tumor recurrence. We discuss the value of a completion lymphadenectomy in light of the uncertainties facing this management strategy for melanoma. J. Surg. Oncol. 2016;114:281–287.

AB - In the United States, approximately half of patients with a positive sentinel lymph node biopsy undergo a completion lymphadenectomy. Because of the equivocal survival benefits in pursuing a completion lymphadenectomy in these patients, surgeons must weigh the postoperative morbidity of the operation with concerns facing a patient's quality of life and risk of tumor recurrence. We discuss the value of a completion lymphadenectomy in light of the uncertainties facing this management strategy for melanoma. J. Surg. Oncol. 2016;114:281–287.

KW - lymphadenectomy

KW - melanoma

KW - sentinel lymph node

KW - value

UR - http://www.scopus.com/inward/record.url?scp=84983250944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983250944&partnerID=8YFLogxK

U2 - 10.1002/jso.24273

DO - 10.1002/jso.24273

M3 - Review article

C2 - 27444517

AN - SCOPUS:84983250944

VL - 114

SP - 281

EP - 287

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -

Access to Document

10.1002/jso.24273